Åke Wennmalm
#151,572
Most Influential Person Now
Åke Wennmalm's AcademicInfluence.com Rankings
Åke Wennmalmphilosophy Degrees
Philosophy
#8393
World Rank
#11769
Historical Rank
Ontology
#98
World Rank
#109
Historical Rank
Logic
#5432
World Rank
#6833
Historical Rank
Download Badge
Philosophy
Why Is Åke Wennmalm Influential?
(Suggest an Edit or Addition)Åke Wennmalm's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. (1993) (417)
- Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin (1992) (306)
- Both physical fitness and acute exercise regulate nitric oxide formation in healthy humans. (1997) (275)
- Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia. (1976) (212)
- The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. (1987) (194)
- Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury (1994) (185)
- Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. (1996) (137)
- Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. (1994) (126)
- Increased nerve stimulation induced release of noradrenaline from the rabbit heart after inhibition of prostaglandin synthesis. (1971) (125)
- Relation Between Tobacco Use and Urinary Excretion of Thromboxane A2 and Prostacyclin Metabolites in Young Men (1991) (115)
- Facilitation of sympathetic neurotransmission in the cat spleen after inhibition of prostaglandin synthesis. (1971) (110)
- Endothelial nitric oxide and cardiovascular disease (1994) (106)
- Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. (1996) (102)
- Detection of endothelial-derived relaxing factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. (1990) (98)
- Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man. (1978) (97)
- Inhibition by prostaglandin E2 of sympathetic neurotransmission in the rabbit heart. (1970) (96)
- Studies on mechanisms controlling the secretion of neurotransmitters in the rabbit heart. (1971) (91)
- Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. (2001) (88)
- Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. (1990) (86)
- Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. (1994) (84)
- Hypoxia causes prostaglandin release from perfused rabbit hearts. (1974) (83)
- Conversion of inhaled nitric oxide to nitrate in man (1995) (79)
- Influence of indomethacin on the systemic and pulmonary vascular resistance in man. (1978) (79)
- INHIBITION BY NICOTINE OF THE FORMATION OF PROSTACYCLIN‐LIKE ACTIVITY IN RABBIT AND HUMAN VASCULAR TISSUE (1980) (76)
- Coronary flow regulation in patients with ischemic heart disease: release of purines and prostacyclin and the effect of inhibitors of prostaglandin formation. (1985) (74)
- Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. (1983) (74)
- Augmented noradrenaline release following nerve stimulation after inhibition of prostaglandin synthesis with indomethacin. (1972) (73)
- Comparison of the Effects of Prostaglandins E1, E2 and F2α on the Sympathetically Stimulated Rabbit Heart (1971) (72)
- Evidence for an extra-renal origin of urinary prostaglandin E2 in healthy men. (1979) (71)
- Release of two vasodilators, adenosine and prostacyclin, from isolated rabbit hearts during controlled hypoxia. (1983) (70)
- Public Health Care Management of Water Pollution with Pharmaceuticals: Environmental Classification and Analysis of Pharmaceutical Residues in Sewage Water (2005) (70)
- Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide-stimulated cerebral blood flow in man. (1983) (69)
- Effect of indomethacin on basal and carbon dioxide stimulated cerebral blood flow in man (1981) (68)
- In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. (1986) (67)
- EFFECTS OF NICOTINE ON CARDIAC PROSTAGLANDIN AND PLATELET THROMBOXANE SYNTHESIS (1978) (65)
- Central and peripheral haemodynamic effects of non-steroidal anti-inflammatory drugs in man. (1984) (61)
- Prostaglandins contribute to the vasodilation induced by nicotinic acid. (1979) (60)
- RELEASE OF PROSTAGLANDIN FROM THE RABBIT ISOLATED HEART FOLLOWING VAGAL NERVE STIMULATION OR ACETYLCHOLINE INFUSION (1974) (56)
- Diurnal variation of flow-mediated vasodilation in healthy premenopausal women. (2000) (55)
- Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. (1996) (52)
- On the release of prostaglandin E2 from the rabbit heart following infusion of noradrenaline. (1973) (52)
- Inhibition by prostaglandin E1 of parasympathetic neurotransmission in the rabbit hheart. (1971) (52)
- NICOTINE INHIBITS HYPOXIA‐ AND ARACHIDONATE‐INDUCED RELEASE OF PROSTACYCLIN‐LIKE ACTIVITY IN RABBIT HEARTS (1980) (52)
- Tobacco Use and Urinary Excretion of Thromboxane A2 and Prostacyclin Metabolites in Women Stratified by Age (1992) (51)
- The role of adenosine and prostacyclin in coronary flow regulation in healthy man. (1989) (48)
- Cigarette Smoking Increases Thromboxane A2 Formation without Affecting Platelet Survival in Young Healthy Females (1992) (46)
- Increase in nitric oxide formation after chronic voluntary exercise in spontaneously hypertensive rats. (1998) (42)
- Effect of exercise on human arterial and regional venous plasma concentrations of prostaglandin E. (1978) (42)
- Increased renal excretion of noradrenaline in rats after treatment with prostaglandin synthesis inhibitor indomethacin. (1971) (39)
- Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization (2010) (39)
- Interaction of nicotine and prostaglandins in the cardiovascular system. (1982) (38)
- Pharmaceutical management through environmental product labeling in Sweden. (2009) (38)
- Endothelium‐Dependent and ‐Independent Vasodilation and Reactive Hyperemia in Healthy Smokers (1992) (37)
- Prostacyclin infusion in patients with acute myocardial infarction. (1985) (36)
- Preferential secretion of newly formed noradrenaline in the perfused rabbit heart. (1970) (36)
- Nicotine inhibits vascular prostacyclin but not platelet thromboxane formation. (1983) (36)
- Prostaglandin mediated inhibition of noradrenaline release at different nerve impulse frequencies. (1973) (36)
- Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans. (1988) (36)
- Excretion of thromboxane metabolites in healthy women after cessation of smoking. (1993) (35)
- Prostaglandin‐mediated inhibition of noradrenaline release (1979) (35)
- Conversion of arachidonic acid to prostaglandins in homogenates of human skeletal muscle and kidney. (1979) (34)
- Effect of cigarette smoking on basal and carbon dioxide stimulated cerebral blood flow in man. (1982) (33)
- Prostaglandin E1 as inhibitor of the sympathetic neuroffector system in the rabbit heart. (1970) (32)
- Prostacyclin-dependent coronary vasodilation in rabbit and guinea pig hearts. (1979) (32)
- Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia. (1995) (31)
- Prostaglandin-mediated inhibition of noradrenaline release: III. Separation of prostaglandins released from stimulated hearts and analysis of their neurosecretion inhibitory capacity. (1978) (31)
- Prostaglandin release and mechanical perfromance in the isolated rabbit heart during induced changes in the internal environment. (1975) (31)
- Quantitative evaluation of release and reuptake of adrenergic transmitter in the rabbit heart. (1971) (30)
- NICOTINE STIMULATES PROSTAGLANDIN FORMATION IN THE RABBIT HEART (1977) (30)
- Nitric Oxide Synthesis and Metabolism in Man (1994) (30)
- Intrathecal Release of Nitric Oxide in Alzheimer’s Disease and Vascular Dementia (2000) (29)
- A study on the role of endogenous prostaglandins in the development of exercise-induced and post-occlusive hyperemia in human limbs. (1979) (28)
- Pulmonary formation of prostacyclin in man. (1981) (27)
- Nicotine inhibits the release of 6-keto-prostaglandin F1alpha from the isolated perfused rabbit heart. (1978) (27)
- Excretion of thromboxane A2 and prostacyclin metabolites before and after exercise testing in patients with and without signs of ischemic heart disease. (1990) (27)
- Human forearm and kidney conversion of arachidonic acid to prostaglandins. (1979) (26)
- Estimation of total rate of formation of nitric oxide in the rat. (1998) (25)
- Cardiac synthesis of prostaglandins from arachidonic acid in man. (1980) (25)
- Effect of nicotine on prostacyclin formation in rat aorta. (1983) (24)
- Effect of nitric oxide gas on platelets during open heart operations. (1998) (24)
- Prostaglandin-mediated inhibition of noradrenaline release: V. A comparison of the neuroinhibitory effect of three prostaglandins: E2, I2, and 6-keto-PGF1alpha. (1978) (24)
- NO‐dependent and ‐independent elevation of plasma levels of insulin and glucose in rats by L‐arginine (1994) (23)
- Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia. (1994) (23)
- The arginine-nitric oxide pathway in thrombotic microangiopathy. (1997) (22)
- Inhibition of the release of adrenergic transmitter by a fatty acid in the perfusate from sympathetically stimulated rabbit heart. (1971) (22)
- Maintained hyperexcretion of thromboxane A2 metabolite in healthy young cigarette smokers: results from a prospective study in randomly sampled males with stable smoking habits. (1993) (21)
- Oxygen consumption in rabbit Langendorff hearts perfused with a saline medium. (1981) (21)
- Smoke-derived nitric oxide and vascular prostacyclin are unable to counteract the platelet effect of increased thromboxane formation in healthy female smokers. (1996) (20)
- Turnover of plasma free arachidonic and oleic acids in men and women. (1975) (20)
- Prostaglandin-mediated inhibition of noradrenaline release: IV. Prostaglandin synthesis is stimulated by myocardial adrenoceptors differing from the alpha- and beta-type. (1978) (20)
- Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients. (1990) (20)
- Effect of nicotine on the formation of prostacyclin‐like activity and thromboxane in rabbit aorta and platelets (1984) (20)
- Human platelet thromboxane synthesis is unaffected by nicotine (1981) (19)
- L-arginine-induced hypotension in the rat: evidence that NO synthesis is not involved. (1994) (19)
- Epidural anaesthesia prolonged into the postoperative period prevents stress response and platelet hyperaggregability after peripheral vascular surgery. (1994) (19)
- Role of nitric oxide in induction of inflammatory fluid secretion by the mucosa of the feline gallbladder. (1996) (19)
- Release of endothelial mediators and sympathetic transmitters at different coronary flow rates in rabbit hearts. (1991) (18)
- A role for platelets in the process of infarct extension? (1985) (18)
- Metabolism and excretion of nitric oxide in man: basal studies and clinical applications. (1995) (17)
- Plasma nitrate as an index of immune system activation in animals and man. (1993) (17)
- Participation of prostaglandins in the regulation of peripheral vascular resistance. (1982) (17)
- Subject Index Vol. 11, 2000 (2000) (16)
- Seasonal variations in cyclic GMP response on whole-body cooling in women with primary Raynaud's phenomenon. (1997) (16)
- Effect of nicotine on the formation of prostaglandins in the rabbit kidney. (1981) (16)
- Co-variation between walking ability and circulatory alterations in patients with intermittent claudication. (1992) (16)
- Effect of prostaglandin synthesis inhibitors on basal and CO2-stimulated cerebral blood flow in man. (1983) (16)
- Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication. (1988) (15)
- Effects of hydrodynamic forces on coronary production of prostacyclin and purines. (1989) (15)
- Prostacyclin as neuromodulator in the sympathetically stimulated rabbit heart. (1987) (15)
- Transformation of subcutaneous nitric oxide into nitrate in the rat. (1997) (15)
- Effect of adenosine on the formation of prostacyclin in the rabbit isolated heart (1988) (15)
- Adenosine‐induced coronary release of prostacyclin at normal and low pH in isolated heart of rabbit (1985) (15)
- Intrathecal Release of Nitric Oxide and Its Relation to Final Brain Damage in Patients with Stroke (2000) (15)
- Role of the coronary endothelium in the regulation of sympathetic transmitter release in isolated rabbit hearts. (1989) (15)
- Endothelin does not affect aggregation of human platelets. (1990) (14)
- Quantitative estimation of secretion and reuptake of adrenergic transmitter in the rabbit heart. (1971) (13)
- 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion. (1992) (13)
- Cigarette smoking, prostaglandins and reactive hyperemia. (1979) (13)
- Comparison of the effects of prostaglandins E 1, E 2 and F 2 alpha on the sympathetically stimulated rabbit heart. (1971) (13)
- Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects. (1997) (13)
- HYPOTHESES. Coffee, catecholamines and cardiac arrhythmia (1989) (13)
- Relation between tobacco consumption and urinary excretion of thromboxane A2 and prostacyclin metabolites in 756 randomly sampled young men. (1991) (13)
- Prostaglandin-mediated inhibition of noradrenaline release: II. Dual mechanism behind its frequency-dependence. (1978) (12)
- Nicotine mediated release of prostaglandin E from the rabbit heart. (1976) (12)
- Arachidonic acid metabolism and regulation of blood flow: effect of indomethacin on cutaneous and subcutaneous reactive hyperaemia in humans. (1983) (12)
- Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. (1991) (12)
- Effect of prostacyclin on the severity of ischaemic injury in rabbit hearts subjected to coronary ligation. (1986) (11)
- Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. (1990) (11)
- Turnover of a Prostaglandin Precursor, Arachidonic Acid, in Rheumatoid Arthritis (1975) (11)
- Endothelin has no positive inotropic effect in guinea-pig atria or papillary muscle. (1990) (11)
- Prostacyclin infusion in patients with acute myocardial infarction (preliminary report) (1983) (11)
- An 18oxygen inhalation method for determination of total body formation of nitric oxide in humans. (1999) (11)
- Platelet aggregability in smoking and non-smoking subjects. (1983) (10)
- Cardiac formation of prostacyclin during cardioplegia in man. (1982) (10)
- High and low response in relation to nitric oxide formation but not to lipid peroxidation in patients with sepsis (2003) (10)
- On the relative importance of extra-neuronal uptake of noradrenaline released by nerve stimulation in the rabbit heart. (1973) (10)
- Endothelium-derived constricting factor(s): the last novelty--endothelin. (1990) (10)
- Catecholaminergic defense against hypothermia during brief cold exposure. (1973) (9)
- Urinary albumin excretion and heart rate variability in obese women (1998) (9)
- Mitigation of the Pharmaceutical Outlet into the Environment – Experiences from Sweden (2008) (9)
- Inhibition by prostaglandin E-1 of the sympathetic neuromuscular transmission in the rabbit heart. (1970) (9)
- Prostaglandin-mediated inhibition of noradrenaline release: its resistance to variations in rate of prostaglandine synthesis. (1976) (8)
- Prostaglandin-mediated inhibition of noradrenaline release: IV. Prostaglandin synthesis is stimulated by myocardial adrenoceptors differing from the α- and β-type (1978) (8)
- Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. (1983) (8)
- Effects of Hypothermia on Norepinephrine Release and Effector Response in Isolated Perfused Cat Spleen (1970) (8)
- Nicotinic acid stimulates prostaglandin synthesis in the rabbit heart without releasing noradrenaline. (1978) (7)
- Acipimox stimulates skin blood flow by a cyclo-dxygenase-dependent mechanism (2007) (7)
- Coffee, catecholamines and cardiac arrhythmia. (1989) (7)
- Maintenance of noradrenaline synthesis in rats after reserpine treatment. (1968) (7)
- Detection of a ∼100 kD protein with strong immunoreactivity to antibodies specific for inducible nitric oxide synthase (iNOS) but without NOS activity in neutrophils of patients suffering from sepsis: Results of a preliminary study (1999) (6)
- Paired analysis of thromboxane and prostacyclin metabolites in urine from healthy mothers and their children. (1990) (6)
- Prostaglandin-mediated inhibition of noradrenaline release. VI. On the intra-cardiac source of prostaglandins released from isolated rabbit hearts. (1979) (6)
- Release of adenosine and prostacyclin from ischemic human hearts. (1983) (6)
- The insulin secretory response to intravenous glucose in the rat is independent of NO formation. (1995) (6)
- Vasodilatory action of arachidonic acid in humans following indomethacin treatment. (1977) (6)
- Experiences with the Swedish Environmental Classification Scheme (2010) (6)
- Human renal allograft blood flow, oxygen extraction, and prostaglandin release: their bearing on graft function. (1984) (5)
- Formation of prostacyclin during administration of β1-selective and non-selective β-adrenergic antagonists in healthy humans (1992) (5)
- Analysis of nitrite as a marker for endothelium-derived relaxing factor in biological fluids using electron paramagnetic resonance spectrometry (1991) (5)
- Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. (1996) (5)
- Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans. (1987) (5)
- Differentiation of vasoconstrictor sensitivity caused by prostaglandin E in peripheral vascular beds of the rabbit. (1977) (4)
- Pharmaceuticals: Environmental Effects (2019) (4)
- Prostaglandin therapy for peripheral vascular disease - better than placebo? (1982) (4)
- Metabolic and myogenic components of reactive hyperaemia in the human calf. (1991) (4)
- Transmitter release and adrenergic mechanical responses in the heart: effect of papaverine and imidazole. (1977) (4)
- Prostaglandin-mediated inhibition of noradrenaline release. VII. Effect of indomethacin on some cardiovascular reflexes in man. (1983) (3)
- Dietary cholesterol induces transient changes in plasma nitrate levels in rabbits that are correlated to microcirculatory changes. (1996) (3)
- Acute myocardial infarction and the arachidonic acid system in the coronary vessels. (1985) (3)
- Effect of aminophylline on plasma and urinary catecholamine levels during heavy leg exercise in healthy young men. (1989) (3)
- Application of a new technique--blood pressure clamping--for analysis of prostaglandin interference with sympathetic neurotransmission in man. (1989) (3)
- Nicotinic acid stimulates prostaglandin synthesis in the rabbit heart without releasing noradrenaline (1978) (3)
- L-arginine inhibits noradrenaline release in sympathetically stimulated rabbit hearts. (1989) (3)
- Nitric oxide (NO) in the cardiovascular system. Some physiological and evolutionary aspects. (1992) (2)
- Influence of indomethacin on the systemic and pulmonary vascular resistance in man (1978) (2)
- Release of prostacyclin into the coronary venous blood in patients with coronary arterial disease. (1983) (2)
- Prostaglandins and cardiovascular function: some biochemical and physiological aspects. (1979) (2)
- Endothelium-independent vascular relaxation by histamine in the rabbit aorta. (1991) (2)
- Pharmaceuticals – Permanent Pollutants in Environment Basic facts and proposed measures to protect the public health and the environment (2009) (2)
- Endogenous prostaglandins as regulators of autonomic neurotransmission in the rabbit heart. (1976) (2)
- Role of eicosanoids in the cardiovascular system. (1988) (2)
- Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. (1987) (2)
- Formation of prostacyclin during administration of beta 1-selective and non-selective beta-adrenergic antagonists in healthy humans. (1992) (2)
- Effect of cigarette smoking on reactive hyperaemia in the human finger. (1983) (2)
- Prostaglandin-mediated inhibition of noradrenaline release: II. Dual mechanism behind its frequency-dependence (1978) (1)
- [A new face of atherosclerosis. New discoveries about the role of nitric oxide result in complementary therapy methods]. (1994) (1)
- Effect of adenosine/ADO/ on prostacyclin/PGI2/formation in the heart (1987) (1)
- Turnover of a Prostaglandin Precursor, Arachidonic Acid, in Rheumatoid Arthritis (1975) (1)
- The Normal Metabolic Fate of Nitric Oxide (1999) (1)
- Cardiac prostaglandin formation in man. (1980) (1)
- Detection of an approximately 100 kD protein with strong immunoreactivity to antibodies specific for inducible nitric oxide synthase (iNOS) but without NOS activity in neutrophils of patients suffering from sepsis: results of a preliminary study. (1999) (1)
- Hypoxia-induced prostaglandin release from rabbit heart. (1975) (1)
- Prostaglandins and the Heart (1980) (1)
- Hypoxia elicits liberation of anti-aggregatory substances from isolated rabbit hearts. (1983) (1)
- Excretion of Thromboxane A 2 and Prostacyclin Metabolites Before and After Exercise Testing in Patients With and Without Signs of Ischemic Heart Disease (2005) (1)
- Prostacyclin offers protection against early extension of acute myocardial infarction. (1987) (1)
- Nicotine inhibits prostacyclin formation in vascular tissue*1 (1979) (1)
- Prostacyclin and regional coronary blood flow in experimental myocardial infarction. (1988) (1)
- Increased Plasma Levels of Nitric Oxide Metabolite in Healthy Humans Exercising with Reduced Leg Perfusion (1994) (0)
- Tobacco Consumption and Urinary Cotinine Concentration in Study Groups Daily tobacco Accumulated tobacco Cotinine in urine consumption consumption Tobacco (2005) (0)
- Tobacco Use and Urinary Excretion of Thromboxane A2 and Prostacyclin Metabolites (2005) (0)
- Coronary flowregulation inpatients withischemic heartdisease: release ofpurines andprostacyclin andtheelfect ofinhibitors ofprostaglandin formation (1985) (0)
- Invivoproduction ofprostacyclin andthromboxane inpatients with acutemyocardial infarction (1986) (0)
- MYOCARDIAL ISCHAEMIA TRIGGERS FORMATION OF THROMBOXANE (1987) (0)
- Cardiovascular prostaglandins: some comments on their involvement in circulatory physiology and pathophysiology. (2009) (0)
- Contents Vol. 11, 2000 (2000) (0)
- Plasma Levels of Nitrate and Methemoglobin in Eight Healthy Volunteers in the Basal State and During Inhalation of Nitric Oxide (2005) (0)
- [Does nitric oxide cause pulmonary hypertension? A new report with new questions]. (1996) (0)
- [How the Stockholm County Council works to reduce the environmental impact of drugs]. (2010) (0)
- [NO (nitric oxide)--at the threshold of clinical medicine]. (1992) (0)
- 18-OXYGEN INHALATION METHOD FOR DETERMINATION OF TOTAL BODY FORMATION OF NITRIC OXIDE IN HUMANS (1997) (0)
- [Nitric oxide. A new drug in lung disease?]. (1993) (0)
- Prostaglandin-mediated inhibition of noradrenaline release: III. Separation of prostaglandins released from stimulated hearts and analysis of their neurosecretion inhibitory capacity (1978) (0)
- Transitory failure of ADP to induce platelet aggregation in plasma from a young healthy woman. (1980) (0)
- [Mark Twain, the conscience and modern smoking cessation campaigns]. (1991) (0)
- [Drugs and the environment in practice. What can counties and regions to do?]. (2012) (0)
- 838 INCREASED PLASMA LEVELS OF NITRIC OXIDE METABOLITE IN HEALTHY HUMANS EXERCISING WITH REDUCED LEG PERFUSION (1994) (0)
- Effect of prostanoids on the coronary circulation (1984) (0)
- [Smoking and heart infarct--a relationship based on the inhibition of the body's prostacyclin production?]. (1980) (0)
- Outflow of Prostacyclin in the Isolated Rabbit Heart (2005) (0)
- Conversion ofinhaled nitric oxide tonitrate inman (1995) (0)
- [The 4S study is convincing--without explanation]. (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Åke Wennmalm?
Åke Wennmalm is affiliated with the following schools:
